METTL14 mediated m6A modification to LncRNA ZFAS1/ RAB22A: A novel therapeutic target for atherosclerosis

Int J Cardiol. 2021 Apr 1:328:177. doi: 10.1016/j.ijcard.2020.12.002. Epub 2020 Dec 8.

Authors

Chengwu Gong¹, Yun Fan², Jichun Liu³

Affiliations

¹ Department of Cardiothoracic Surgery, Second Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330006, China.
² Department of Neurology and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
³ Department of Cardiothoracic Surgery, Second Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330006, China. Electronic address: [email protected].

PMID: 33301833
DOI: 10.1016/j.ijcard.2020.12.002

No abstract available

Publication types

Letter
Comment

MeSH terms

ADAM10 Protein
Amyloid Precursor Protein Secretases
Atherosclerosis* / drug therapy
Atherosclerosis* / genetics
Cholesterol
Humans
Membrane Proteins
Methyltransferases / metabolism
MicroRNAs*
RNA, Long Noncoding* / genetics
rab GTP-Binding Proteins

Substances

Membrane Proteins
MicroRNAs
RAB22A protein, human
RNA, Long Noncoding
Cholesterol
METTL14 protein, human
Methyltransferases
Amyloid Precursor Protein Secretases
ADAM10 Protein
ADAM10 protein, human
rab GTP-Binding Proteins